If you find a lump or bump somewhere on your body, you may wonder: Is this a cyst? Is it a tumor? What’s the difference? And what should I do? Learn more: spklr.io/6012Ssqa

Andrew T. Chan, MD, MPH, director of Epidemiology at Mass General Cancer Center, is co-leading Team PROSPECT, an international team dedicated to addressing the rising rates of early-onset colorectal cancer. spklr.io/6017SQqt

A major worldwide software outage has affected many of our systems at Mass General Hospital, as well as many major businesses across the country. Due to the severity of this issue, all previously scheduled non-urgent surgeries, procedures, and medical visits are cancelled today.

UPDATE: July 19 – 9:53 pm Mass General Brigham mobilized incident command and other leadership teams across the organization to manage our response to the CrowdStrike incident. As part of this response, we have also deployed hundreds (cont) spklr.io/l/6019Sx0N

Update: 7/20 - 1:15pm Mass General Cancer Center is operational and open to patients. Our response teams are continuing to work diligently throughout the weekend to address the many additional downstream impacts across our system from (cont) spklr.io/l/6014SIFi

Mass General Brigham is operational. Mass General Cancer Center is open and seeing patients. All scheduled appointments and procedures will happen as planned on Monday, July 22.

Celebrating #ChristmasInJuly at the Proton Center! Inspired by a young patient's love for holidays, our center was transformed with festive decorations and gifts. Staff and patients dressed up, creating a joyful, unforgettable celebration. Merry Christmas in July! 🎅🎁🎄

Stay updated on the latest in cancer treatment with our comprehensive clinical review of advances in immuno-oncology. Plus, join an optional session on common and uncommon toxicities. Register: spklr.io/6011Shjf

A new rapid genotyping test cuts brain tumor diagnosis time from 10 days to 2, avoiding invasive biopsies. It accurately identified tumors in 42% of cases with zero false positives. Learn how this is improving patient care. spklr.io/6012sJug

The U.S. FDA has approved a blood test to diagnose for colorectal cancer. Andrew Chan, MD, MPH, director of cancer epidemiology at Mass General Cancer Center, joins WCVB-TV Boston to talk more about the blood test and what it means for patients. spklr.io/6015sMwS

Efren Flores, MD, thoracic radiologist, joins @WBZ radio to discuss the importance of screening for lung cancer. #WorldLungCancerDay spklr.io/6014sOlM

The U.S. FDA approved a blood test to be used for colorectal cancer screening among average-risk adults ages 45 and older. Daniel Chung, MD, Director, High-Risk GI Cancer Clinic, shares with CNN more. spklr.io/6019surf

When Donald Lawrence, MD, treated Matteo Abbruzzese for melanoma in 2013, therapies were limited. Now, due to medical advances that started with cases like Teo’s, Dr. Lawrence sees potential for melanoma to be one of the most curable cancers. spklr.io/6018snGY

What is CAR T-Cell Therapy? How can we use the immune system to fight cancer? What are the latest advancements in cell therapy? Matthew J. Frigault, MD, discusses how cells in the body can provide long-term protection against different types of cancer. spklr.io/6014sXq4

Taking aspirin regularly can significantly reduce the risk of developing colorectal cancer for individuals who have unhealthy habits, according to a team of scientists led by Andrew Chan, MD, MPH, director of cancer (cont) spklr.io/l/6018sdf4

Tumor-infiltrating lymphocytes therapy (TIL) is a form of immunotherapy. TIL cancer therapy boosts your body's natural immune response to improve your ability to fight cancer. Learn more on how TIL therapy works: spklr.io/6012smjM

Edwin Choy, MD, PhD, joins us on Targeted Talks to discuss the recent approval of afami-cel for advanced synovial sarcoma. Tune in NOW for expert insights on this groundbreaking treatment! Mass General Cancer Center Mass General MDs targetedonc.com/view/breaking-…

Rohan Venkatesh found hope in a new and innovative approach to brain cancer treatment that drastically cuts down the time it takes to get a diagnosis from ten days to just two. Read more about Rohan's story via SurvivorNet: spklr.io/6018s0zu

A study led by researchers at Mass General Cancer Center found that an individualized cancer therapy tailored to the unique tumor profiles of patients with melanoma and lung cancer was well-tolerated and boosted immune activity. spklr.io/6019s2jP

David Ryan, MD, Daphne Haas-Kogan, MD, and Gerard Doherty, MD, outline Mass General Brigham's bold blueprint to combat cancer care, drawing on our unique strengths to equitably deliver care throughout our patients' lives. Learn more in The Boston Globe op-ed. spklr.io/6018tmtw